---
schema_version: "secwatch.filing_event.v1"
accession: "0000950142-21-003867"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2021-12-02T23:59:59+00:00"
generated_at: "2026-06-28T04:10:58.284255+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics CFO Rudy Howard resigns effective December 1, 2021

## Summary
- Rudy Howard resigned as CFO and employee effective Dec 1, 2021; no disagreement on operations.
- Severance of $325k/year payable through Dec 31, 2022; potential 2021 discretionary bonus.
- Options scheduled to vest in Dec 2021 (83,333 shares) accelerated; other options forfeited.
- Medical coverage continued at active-employee cost through Dec 31, 2022.
- Separation Agreement includes release, non-disparagement, and cooperation through Dec 31, 2021.

## SEC filing metadata
- accession: 0000950142-21-003867
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2021-12-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000095014221003867/0000950142-21-003867-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000095014221003867/eh210206812_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950142-21-003867
- JSON: https://secwatch.observer/filing/0000950142-21-003867.json
- Plain text: https://secwatch.observer/filing/0000950142-21-003867.txt

## Key facts
- Executive change
  Rudy Howard resigned as Chief Financial Officer at vTv Therapeutics Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On December 1, 2021, (the “Effective Date”) Rudy Howard announced his resignation as Chief Financial Officer and as an employee of vTv Therapeutics Inc. (the “Company”), effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000095014221003867/0000950142-21-003867-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.